PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Meloxicam
Presentation Product Chemical substance Chapter Items dispensed
Meloxicam 15mg tablets
1001010AAAAABAB
Meloxicam Meloxicam Musculoskeletal and Joint Diseases 49,906
Meloxicam 7.5mg tablets
1001010AAAAAAAA
Meloxicam Meloxicam Musculoskeletal and Joint Diseases 41,257
Meloxicam 15mg orodispersible tablets sugar free
1001010AAAAAJAJ
Meloxicam Meloxicam Musculoskeletal and Joint Diseases 173
Meloxicam 7.5mg orodispersible tablets sugar free
1001010AAAAAKAK
Meloxicam Meloxicam Musculoskeletal and Joint Diseases 149
Meloxicam 15mg suppositories
1001010AAAAACAC
Meloxicam Meloxicam Musculoskeletal and Joint Diseases No data available
Meloxicam 15mg/5ml oral suspension
1001010AAAAAIAI
Meloxicam Meloxicam Musculoskeletal and Joint Diseases No data available
Meloxicam 3.75mg/5ml oral suspension
1001010AAAAAGAG
Meloxicam Meloxicam Musculoskeletal and Joint Diseases No data available
Meloxicam 7.5mg suppositories
1001010AAAAADAD
Meloxicam Meloxicam Musculoskeletal and Joint Diseases No data available
Meloxicam 7.5mg/5ml oral suspension
1001010AAAAAHAH
Meloxicam Meloxicam Musculoskeletal and Joint Diseases No data available
Mobic 15mg suppositories
1001010AABBACAC
Mobic Meloxicam Musculoskeletal and Joint Diseases No data available
Mobic 15mg tablets
1001010AABBABAB
Mobic Meloxicam Musculoskeletal and Joint Diseases No data available
Mobic 7.5mg suppositories
1001010AABBADAD
Mobic Meloxicam Musculoskeletal and Joint Diseases No data available
Mobic 7.5mg tablets
1001010AABBAAAA
Mobic Meloxicam Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.